Chronic renal-function disorders during lithium use;Chronische nierfunctiestoornissen bij lithiumgebruik

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 31, 2006, Pages 1715-1718

  Van Gerven, H A J M ^a   Boer, W H ^b  

^a Centrum voor Ambulante Ouderenpsychiatrie Altrecht   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

BIPOLAR DEPRESSION; CARDIOVASCULAR RISK; CHRONIC DISEASE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIALYSIS; DYSLIPIDEMIA; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LONG TERM CARE; MAJOR DEPRESSION; POLYDIPSIA; POLYURIA; PROTEINURIA; RENAL DIABETES; REVIEW;

BIPOLAR DISORDER; DEPRESSIVE DISORDER; DIABETES INSIPIDUS, NEPHROGENIC; HUMANS; KIDNEY FAILURE, CHRONIC; LITHIUM; RISK FACTORS;

EID: 33747402358     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Nederlandse Vereniging voor Psychiatrie. Richtlijn bipolaire stoornissen. 2e herz. dr. Amsterdam: Boom; 2001. p. 43-6.
2. Depressie. Richtlijn voor de diagnostiek en behandeling van volwassen patiënten met een depressie. Houten: Ladenius; 2005.
3. Vestergaard P, Schou M. Lithium treatment in Aarhus. I. Prevalence. Pharmacopsychiatry. 1989;22:99-100.
4. College voor zorgverzekeringen (CVZ). Geneesmiddelen Informatie Project. Amstelveen: CVZ; 2005.
5. Angrist BM, Gershon S, Levitan SJ, Blumberg AG. Lithium-induced diabetes insipidus-like syndrome. Compr Psychiatry. 1970;11:141-6.
6. Hestbech J, Hansen HE, Amdisen A, Olsen S. Chronic renal lesions following long-term treatment with lithium. Kidney Int. 1977;12:205-13.
7. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis. 1987;10:329-45.
8. Gitlin M. Lithium and the kidney: an updated review. Drug Saf. 1999;20:231-43.
9. Von Knorring L, Wahlin A, Nyström K, Bohman S. Uraemia induced by long-term lithium treatment. Lithium. 1990;1:251-3.
10. Gitlin MJ. Lithium-induced renal insufficiency. J Clin Psychopharmacol. 1993;13:276-9.
11. Chugh S, Yager H. End-stage renal disease after treatment with lithium. J Clin Psychopharmacol. 1997;17:495-7.
12. Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D'Agati VD. Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol. 2000;11:1439-48.
13. Presne C, Fakhouri F, Noel LH, Stengel B, Even C, Kreis H, et al. Lithium-induced nephropathy: rate of progression and prognostic factors. Kidney Int. 2003;64:585-92.
14. Bendz H, Aurell M, Lanke J. A historical cohort study of kidney damage in long-term lithium patients: continued surveillance needed. Eur Psychiatry. 2001;16:199-206.
15. Lepkifker E, Sverdlik A, Iancu I, Ziv R, Segev S, Kotler M. Renal insufficiency in long-term lithium treatment. J Clin Psychiatry. 2004;65:850-6.
16. Kincaid-Smith, P, Burrows GD, Davies BM, Holwill B, Walter M, Walker RG. Renal-biopsy findings in lithium and prelithium patients. Lancet. 1979;2(8144):7001.
17. Burrows GD, Davies B, Kincaid-Smith P. Unique tubular lesion after lithium. Lancet. 1978;1(8077):1310.
18. Boer WH, Fransen R, Shirley DG, Walter SJ, Boer P, Koomans HA. Evaluation of the lithium clearance method: direct analysis of tubular lithium handling by micropuncture. Kidney Int. 1995;47:1023-30.
19. Birch NJ, Hullin RP. Lithium and the kidney. Br Med J. 1980;280:1148-9.
20. Tam VK, Green J, Schwieger J, Cohen AH. Nephrotic syndrome and renal insufficiency associated with lithium therapy. Am J Kidney Dis. 1996;27:715-20.
21. Bendz H, Aurell M, Balldin J, Mathé AA, Sjodin I. Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transplant. 1994;9:1250-4.
22. Farres MT, Ronco P, Saadoun D, Remy P, Vincent F, Khalil A, et al. Chronic lithium nephropathy: MR imaging for diagnosis. Radiology. 2003;229:570-4.
23. Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry. 1991;48:1082-8.
24. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003;41:47-55.
25. Zandi-Nejad K, Eddy AA, Glassock RJ, Brenner BM. Why is proteinuria an ominous biomarker of progressive kidney disease? Kidney Int Suppl. 2004;92:S76-89.
26. Ruggenenti P, Perna A, Remuzzi G. ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop. Gruppo Italiano di Studi Epidemiologici in Nefrologia. J Am Soc Nephrol. 2001;12:2832-7.
27. Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE). Lancet. 2003;361:117-24.
28. Finley PR, O'Brien JG, Coleman RW. Lithium and angiotensin-converting enzyme inhibitors. J Clin Psychopharmacol. 1996;16:68-71.
29. Zwanzger P, Marcuse A, Boerner RJ, Walther A, Rupprecht R. Lithium intoxication after administration of ATI blockers. J Clin Psychiatry. 2001;62:208-9.
30. Batlle DC, von Riotte AB, Gaviria M, Grupp M. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med. 1985;312:408-14.
31. Schou M. Forty years of lithium treatment. Arch Gen Psychiatry. 1997;54:9-13.